Effects of indomethacin on bone ingrowth

Abstract
The effects of indomethacin, a nonsteriodal antiinflammatory agent, on bone ingrowth were studied using a rabbit animal model and a porous cylindrical implant system. Bone ingrowth was found to be independent of pore size in the range tested (0.6–1.0 mm). In the control (placebo‐treated) group, there was a significant increase in bone ingrowth between the 2‐ and 8‐week groups of animals. However, in the indomethacin‐treated group, there was no increase in bone ingrowth with time.